Updated April 2006
Patient Involvement
Patient Participation in FDA Regulatory Issues
Articles
Regulatory Information
Related Information
- ClinicalTrials.gov, the National
Institutes of Health Clinical Trials Database
- The MedWatch Program enhances the effectiveness
of postmarketing surveillance of medical products as they are used in clinical
practice to help identify significant health hazards associated with these
products. Visit the MedWatch page and learn how to work with your health
care professional to report possible adverse reactions. The patients identity
is kept confidential. This section also contains extensive information
about the safety of medical products, with summaries of safety-related labeling
changes presented on a month-by-month basis.
- HIV/AIDS Program
- Cancer Liaison Program
- Index to Drug-Specific Information,
a list of consumer drug information sheets that provide basic information
about medications approved by the FDA since 1998. This Index does not include
all FDA approved drugs, only those with consumer Information Sheets and Pages.
Please use Drugs@FDA
to search for information on a drug not found in the Index.
- Food & Drug Interactions
[PDF] .
Many medicines have powerful ingredients that interact within the body in
different ways, and diet and lifestyle can sometimes have a significant
impact on a drug's ability to work in the body. Certain foods, beverages,
alcohol, caffeine can interact with medicines. This brochure (in PDF format)
has information about possible interactions between many common prescription
and nonprescription (over-the-counter) drugs with food, alcohol and caffeine.
National Consumers League, 1998.
PDF documents may be read with a free copy of the Adobe Acrobat Reader.
![horizontal rule](https://webarchive.library.unt.edu/web/20090117050529im_/http://www.fda.gov/graphics/blkpixel.gif)